Market Tracker

07/25 9:39am ET

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.7105
Data as of Jul 24
 0.00 / 0.00%
Today’s Change
0.36
Today|||52-Week Range
1.85
+39.31%
Year-to-Date
No recent news for Rexahn Pharmaceuticals Inc.

Today’s Trading

Previous close0.71
Today’s openn.a.
Day’s range-- - --
Volume1,000
Average volume (3 months)2,005,731
Market cap$125.5M
Dividend yield--
Data as of 07/24/2014

Growth & Valuation

Earnings growth (last year)-16.67%
Earnings growth (this year)-66.67%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.26

Competitors

 Today’s
change
Today’s
% change
CNATConatus Pharmaceutic...0.000.00%
MDGNMedgenics Inc0.000.00%
ARGSArgos Therapeutics I...+0.12+1.83%
CORICorium International...0.000.00%
Data as of 9:35am ET, 07/25/2014

Financials

Next reporting dateSeptember 3, 2014
EPS forecast (this quarter)-$0.02
Annual revenue (last year)$0.00
Annual profit (last year)-$9.5M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Scientist
Chang Ho Ahn
Chief Executive Officer &
Director
Peter David Suzdak
Corporate headquarters
Rockville, Maryland

Forecasts